Onderneming Dar Al-Shifa Pharmaceuticals Company
Aandelen
PHARMACARE
PS2014112861
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
3,35 USD | +4,69% |
|
-.--% | -.--% |
Vakgebied
Aantal werknemers: 423
Verkoop per activiteit
USD in miljoen | 2020 | Gewicht | 2021 | Gewicht | Delta |
---|---|---|---|---|---|
Human Medicines and Medical Supplies
73,7
%
| 18 | 77,3 % | 23 | 73,7 % | +27,28% |
Manufacturing Services
15,2
%
| 4 | 15,2 % | 5 | 15,2 % | +33,09% |
Veterinary Medicines
3,4
%
| 1 | 3,7 % | 1 | 3,4 % | +23,06% |
License Fee
3,3
%
| - | - | 1 | 3,3 % | - |
Other Services
2,1
%
| 1 | 2,2 % | 1 | 2,1 % | +25,66% |
Contracts Services
1,8
%
| 0 | 1,7 % | 1 | 1,8 % | +41,14% |
Share from Profit of Product Development
0,6
%
| - | - | 0 | 0,6 % | - |
Verkoop per regio
USD in miljoen | 2020 | Gewicht | 2021 | Gewicht | Delta |
---|---|---|---|---|---|
Palestine
100,0
%
| 16 | 71,2 % | 31 | 100,0 % | +87,42% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Bassim Nasr
CEO | Chief Executive Officer | - | 01-01-86 |
Maen Hammoudeh
DFI | Director of Finance/CFO | - | - |
Ayman Qaddumi
CTO | Chief Tech/Sci/R&D Officer | - | - |
Tamra Kouba
ADM | Chief Administrative Officer | - | 01-01-98 |
Sandra Nasr
BRD | Director/Board Member | 59 | - |
Sales & Marketing | - | 01-01-17 | |
Foad Qassis
HRO | Human Resources Officer | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Hashim Al-Shawa
BRD | Director/Board Member | 48 | - |
Tawfik Habesch
BRD | Director/Board Member | 62 | - |
Bassim Nasr
CEO | Chief Executive Officer | - | 01-01-86 |
Bassam Yousef
FOU | Founder | 76 | 01-01-86 |
Sandra Nasr
BRD | Director/Board Member | 59 | - |
Director/Board Member | 74 | - | |
Director/Board Member | 50 | - | |
Ramzi Noursi
BRD | Director/Board Member | 55 | - |
Hamza Aloul
BRD | Director/Board Member | 45 | - |
Michael Wirtz
BRD | Director/Board Member | - | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 9 000 000 | 8 909 977 ( 99,00 %) | 0 | 99,00 % |
Bedrijfsgegevens
![Adres Dar Al-Shifa Pharmaceuticals Company(PHARMACARE)](https://cdn.zonebourse.com/static/address/120970010.png)
Sector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
-.--% | 30,15 mln. | |
+55,55% | 823 mld. | |
+42,31% | 641 mld. | |
-6,83% | 352 mld. | |
+17,15% | 324 mld. | |
+7,09% | 301 mld. | |
+14,02% | 241 mld. | |
+1,64% | 223 mld. | |
+13,66% | 218 mld. | |
+7,87% | 167 mld. |
- Beurs
- Aandelen
- Koers PHARMACARE
- Onderneming Dar Al-Shifa Pharmaceuticals Company